Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Lois Lamerato"'
Autor:
Juan Jose Garcia Sanchez, Janani Rangaswami, Like Jiang, Joanna Huang, Tope Olufade, Stephen Nolan, Lois Lamerato
Publikováno v:
Advances in Therapy
Introduction The DAPA-CKD trial assessed dapagliflozin in patients with chronic kidney disease (CKD) with or without type 2 diabetes (T2D). To aid interpretation of results, renal and cardiovascular outcomes plus healthcare resource utilization (HCRU
Autor:
Bing Ying Poon, Alfred I. Neugut, Dawn L. Hershman, Lois Lamerato, Anita L. Stewart, Lawrence H. Kushi, GC Hillyer, Candyce H. Kroenke
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 30:806-807
Purpose: We examined the association between patient experience of care and utilization of hormone therapy (HT) in the treatment of non-metastatic hormone-receptor positive (HR+) breast cancer. Methods: Patients newly diagnosed with non-metastatic br
Publikováno v:
Journal of Wound, Ostomy, and Continence Nursing
Purpose The purpose of this study was to estimate the risk and economic burden of peristomal skin complications (PSCs) in a large integrated healthcare system in the Midwestern United States. Design Retrospective cohort study. Subjects and setting Th
Autor:
Kimberly Baker-Genaw, Kimberlydawn Wisdom, Matthew Cerasale, Iyad Isseh, Oleksandra Lupak, Rashad Farha, Anna Sleder, Shiloh Tackett, Andrew Taylor, William W. O'Neill, Lois Lamerato, Ryhm Radjef, Dana Larkin, Chetan Mittal, George Divine
Publikováno v:
Journal of Racial and Ethnic Health Disparities. 4:1189-1194
We sought to quantify socioeconomic disparities in patients with severe aortic stenosis (AS) undergoing transcatheter aortic valve replacement (TAVR) at an urban, tertiary referral center. This retrospective case-control study identified 67 patients
Autor:
Carol Magai, Alfred I Neugut, Lawrence W Kushi, Jeanne S. Mandelblatt, Grace C Hillyer, Jinjoo Shim, Wei Yann Tsai, Christine B Ambrisone, David Nathanson, Lois Lamerato, Dana H Bovberg, Dawn L Hershman, Judith S Jacobson
Publikováno v:
Cancer Research. 75:P1-11
BACKGROUND Adjuvant chemotherapy for early stage breast cancer decreases recurrence and increases survival. However, early discontinuation of chemotherapy occurs frequently and has a negative influence on patient outcomes. METHODS The Breast Cancer Q
Autor:
Judith S. Jacobson, Dana H. Bovbjerg, Dawn L. Hershman, Jeanne S. Mandelblatt, Donna Buono, Lois Lamerato, Alfred I. Neugut, Grace Clarke Hillyer, S. David Nathanson, Wei-Yann Tsai, Lawrence H. Kushi
For many women with non-metastatic breast cancer, adjuvant chemotherapy prevents recurrence and extends survival. Women who discontinue chemotherapy early may reduce those benefits, but little is known about what predicts early discontinuation. We so
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a22f75de844c2902c8ea928e1626adee
https://europepmc.org/articles/PMC5492513/
https://europepmc.org/articles/PMC5492513/
Autor:
Carol Magai, Alfred I. Neugut, Dana H. Bovbjerg, Lawrence H. Kushi, Judith S. Jacobson, Jeanne S. Mandelblatt, Dawn L. Hershman, Christine B. Ambrosone, Nicole Leoce, Grace Clarke Hillyer, S. David Nathanson, Wei-Yann Tsai, Lois Lamerato
Publikováno v:
Breast Cancer Research and Treatment. 134:419-428
Adjuvant hormonal therapy for non-metastatic hormone receptor (HR)-positive breast cancer decreases risk of breast cancer recurrence and increases survival. However, some women do not initiate this life-saving treatment. We used a prospective cohort
Publikováno v:
Journal of Clinical Sleep Medicine. :9-18
Study Objectives:In order to provide a comprehensive estimate of the health risks for OSA patients, we analyzed multiple outcomes and independent predictors of these outcomes in an OSA population e...
Autor:
John Corbelli, Dinara Makenbaeva, Karina Berenson, Essy Mozaffari, Lois Lamerato, Roman Casciano
Publikováno v:
Advances in Therapy. 27:564-579
Previous studies have demonstrated increased costs associated with bleeding in clinical trials, but none have yet examined the association of bleeding with costs/charges in a real-world setting. This study examines the association between health care
Autor:
Fujie, Xu, Anne C, Moorman, Xin, Tong, Stuart C, Gordon, Loralee B, Rupp, Mei, Lu, Eyasu H, Teshale, Philip R, Spradling, Joseph A, Boscarino, Connie M, Trinacty, Mark A, Schmidt, Scott D, Holmberg, Jim, Xing, David R, Nerenz, Lois, Lamerato, Yan, Wang, Nonna, Akkerman, Nancy, Oja-Tebbe, Talan, Zhang, Jia, Li, Alexander, Sitarik, Dana, Larkin, Zahra S, Daar, Patrick J, Curry, Robert E, Smith, Vinutha, Vijayadeva, John V, Parker, Judy L, Donald, Erin M, Keast
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 62(3)
Background A key question in care of patients with chronic hepatitis C virus (HCV) infection is beginning treatment immediately vs delaying treatment. Risks of mortality and disease progression in "real world" settings are important to assess the imp